Enhanced GST and HO-1 mRNA levels in T2D-PDT, compared to PDT patients, might be explained by an attempt to afford extra biological protection against superoxide generation observed in hyperglycemic states [35]. The gene discussed is HMOX1; the disease is type 2 diabetes mellitus.